GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (STU:2TZ) » Definitions » Cyclically Adjusted FCF per Share

Tianjin Pharmaceutical Da Ren Tang Group (STU:2TZ) Cyclically Adjusted FCF per Share : €0.04 (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Tianjin Pharmaceutical Da Ren Tang Group's adjusted free cash flow per share for the three months ended in Mar. 2025 was €0.055. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.04 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Tianjin Pharmaceutical Da Ren Tang Group's average Cyclically Adjusted FCF Growth Rate was 24.40% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 16.70% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 21.10% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 20.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Tianjin Pharmaceutical Da Ren Tang Group was 100.00% per year. The lowest was 9.50% per year. And the median was 20.10% per year.

As of today (2025-05-07), Tianjin Pharmaceutical Da Ren Tang Group's current stock price is €1.8962. Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was €0.04. Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted Price-to-FCF of today is 47.41.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Tianjin Pharmaceutical Da Ren Tang Group was 306.50. The lowest was 51.76. And the median was 81.41.


Tianjin Pharmaceutical Da Ren Tang Group Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group Cyclically Adjusted FCF per Share Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 0.01 0.03 0.04

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.03 0.03 0.04 0.04

Competitive Comparison of Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted Price-to-FCF falls into.


;
;

Tianjin Pharmaceutical Da Ren Tang Group Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Tianjin Pharmaceutical Da Ren Tang Group's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.055/115.1156*115.1156
=0.055

Current CPI (Mar. 2025) = 115.1156.

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.012 99.500 0.014
201509 -0.015 100.500 -0.017
201512 0.030 100.600 0.034
201603 0.017 102.200 0.019
201606 0.002 101.400 0.002
201609 0.000 102.400 0.000
201612 0.032 102.600 0.036
201703 -0.002 103.200 -0.002
201706 0.002 103.100 0.002
201709 -0.014 104.100 -0.015
201712 -0.006 104.500 -0.007
201803 0.025 105.300 0.027
201806 0.001 104.900 0.001
201809 0.007 106.600 0.008
201812 -0.003 106.500 -0.003
201903 0.014 107.700 0.015
201906 0.001 107.700 0.001
201909 0.009 109.800 0.009
201912 0.024 111.200 0.025
202003 0.014 112.300 0.014
202006 0.021 110.400 0.022
202009 0.011 111.700 0.011
202012 0.034 111.500 0.035
202103 0.012 112.662 0.012
202106 0.037 111.769 0.038
202109 0.046 112.215 0.047
202112 0.024 113.108 0.024
202203 0.006 114.335 0.006
202206 0.000 114.558 0.000
202209 0.004 115.339 0.004
202212 0.089 115.116 0.089
202303 0.025 115.116 0.025
202306 -0.014 114.558 -0.014
202309 -0.010 115.339 -0.010
202312 0.092 114.781 0.092
202403 -0.017 115.227 -0.017
202406 0.103 114.781 0.103
202409 -0.005 115.785 -0.005
202412 0.055 114.893 0.055
202503 0.055 115.116 0.055

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Tianjin Pharmaceutical Da Ren Tang Group  (STU:2TZ) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=1.8962/0.04
=47.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Tianjin Pharmaceutical Da Ren Tang Group was 306.50. The lowest was 51.76. And the median was 81.41.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Tianjin Pharmaceutical Da Ren Tang Group Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Pharmaceutical Da Ren Tang Group Business Description

Traded in Other Exchanges
Address
No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.

Tianjin Pharmaceutical Da Ren Tang Group Headlines

No Headlines